학술논문
Efficacy and Safety of Mirikizumab in a Randomized Phase 2 Study of Patients With Crohn’s Disease
Document Type
Article
Author
Source
In Gastroenterology February 2022 162(2):495-508
Subject
Language
ISSN
0016-5085